🎉 Innovation Spotlight at Pharmidex! 🎉
May 27, 2025
We are proud to announce the integration of the
Jess™ /
Wes™
Automated Western Blotting Systems by Bio-Techne into our platform bringing next-generation protein analysis capabilities to our drug discovery and development workflows.
These Simple Western™ systems transform traditional Western blotting by automating and streamlining the entire process, delivering:
✅ High sensitivity and quantitation down to picogram levels
✅ Hands-free automation with results in just 3 hours
✅ Reproducible, publication-quality data
✅ Minimal sample and reagent use
✅ Multiplex detection with chemiluminescence or fluorescence
This technology allows
Pharmidex to generate fast, reproducible and quantitative protein data, enabling our clients and collaborators to accelerate biomarker validation, mechanism-of-action studies, and more.
Another step forward in our mission to support smarter, faster drug development.
We’re proud to announce that Pharmidex has joined the Good Clinical Practice (GCP) Network , a global collaboration advancing ICH-GCP excellence in clinical research. For us, quality and data integrity are not box-ticking exercises, they are fundamental to credible science and responsible drug development. From pre-clinical research through to clinical delivery, we are committed to: • Regulatory rigour • Ethical conduct • Participant protection • Scientifically robust data Joining the GCP Network further strengthens that commitment. We look forward to contributing to a global community dedicated to raising the bar across clinical research.
Pharmidex now offers integrated in vivo CAR-T study support , combining robust in-life pharmacology with advanced f low cytometry –based cellular analysis. We support early-stage CAR-T and cell therapy programmes with translational data on efficacy, expansion, persistence and phenotype delivered through a single collaborative CRO partner. Let’s talk. 🌐 www.pharmidex.com
Pharmidex is pleased to share that Janette Dalay Robertson will be attending the Founders Growth Community Meeting and Networking x Innovate Cambridge event at The Glasshouse, Cambridge. Janette will be available to meet between 12:00–15:30 and looks forward to connecting with fellow attendees to explore new alliances in pre-clinical and clinical drug development. If you’re attending, let’s connect.
